All In Biotech

Drug Trial Radar · NCT07234864

Study to Assess Safety, Tolerability, PK, and PD of Multiple Doses of ZE63-0302 Administrated Orally in T2DM Patients.

An Exploratory Randomised, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZE63-0302 in Participants With Type 2 Diabetes Mellitus

Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

60

Actual

Start

Nov 19, 2025

Primary completion

Apr 21, 2026

Study completion Jul 9, 2026

Sponsor

Lead sponsor
Eilean TherapeuticsIndustry
Sponsor type
Industry
First posted
Nov 19, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 1b study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of multiple doses of ZE63-0302 administrated orally in T2DM patients.

Conditions

  • Type 2 Diabetes

Interventions

  • ZE63-0302Drug

    Oral capsules BID

  • PlaceboDrug

    Oral capsules BID

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of AE/SAE.Time frame: From dosing to Week 4.
  2. Change from baseline throughout the study in the vital signs and physical examination findings.Time frame: From dosing to Week 4.
  3. Change from baseline throughout the study in 12-lead electrocardiogram resultsTime frame: From dosing to Week 4
  4. Change from baseline throughout the study in Clinical laboratory assessments.Time frame: From dosing to Week 4.

Locations

10 sites in 3 countries. Site status is shown where the registry gives one.

  • Emeritus Research Sydney

    Botany, New South Wales, Australia

  • Momentum Clinical Research Taringa

    Brisbane, Queensland, Australia

  • Momentum Clinical Research Sunshine

    Melbourne, Victoria, Australia

  • Emeritus Research Camberwell

    Melbourne, Victoria, Australia

  • PCRN Rotorua

    Rotorua, Bay of Plenty, New Zealand

  • PCRN Christchurch

    Christchurch, Canterbury, New Zealand

  • Momentum Dunedin

    Dunedin, Otago, New Zealand

  • PCRN Waikato

    Hamilton, Waikato Region, New Zealand

  • Momentum Wellington

    Wellington, Wellington Region, New Zealand

  • The Republican Specialized Scientific and Prectical Medical Center of Endocrinology named after Academician Yo. Kh. Turakulov

    Tashkent, Tashkent, Uzbekistan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.